A drug that was developed to treat pancreatic cancer has now been shown to increase symptom-free survival in preclinical medulloblastoma models – all without showing signs of toxicity. Medulloblastoma is the most common malignant brain tumor in children. Survival rates vary according to which one of the four subtypes...

Drug developed for pancreatic cancer shows promise against most aggressive form of medulloblastoma

SurvivorNet

Discover how precision medicine and immunotherapy are transforming cancer treatment by utilizing genetic profiling and advanced sequencing techniques to provide personalized, targeted care with fewer side effects and improved outcomes.

Tailoring Cancer Treatment to the Patient: The Importance of Biomarker Testing in Precision Medicine

New York City, NY

The Mount Sinai Hospital / Mount Sinai School of Medicine. New York, NY [August 16, 2024]—Scientists at the Icahn School of Medicine at Mount Sinai have identified a new class of RNAs packed into tiny particles known as extracellular vesicles (EVs) that could revolutionize how cancer and other diseases are diagnosed. The team found that these molecules undergo changes when cancer is present, suggesting their potential as biomarkers for detecting prostate cancer or as targets for therapy. The work, led by Navneet Dogra, PhD, Edgar Gonzalez-Kozlova, PhD, Tzu-Yi Chen, PhD, and Gustavo Stolovitzky, PhD, published in the August 16 online issue of Journal of Extracellular Vesicles [DOI: 10.1002/jev2.12481].

Mount Sinai researchers discover novel nanoparticles in blood with potential to transform cancer diagnosis

Cancer Health

In 2006, Diana Lindsay, who had never so much as held a cigarette, was diagnosed with stage 4 lung cancer. It had metastasized to both lungs, her brain and lymph nodes. Keith Eaton, MD, PhD, clinical director of thoracic, head and neck medical oncology at Fred Hutch Cancer Center, told her that a typical patient in this situation would have about nine months to live. But he also observed that she seemed remarkably strong and vital. “He said, ‘You don’t look like my normal lung cancer patient,’” said Lindsay, who had just returned from a business trip to Europe. She was 54 at the time. “He didn’t want to take away the health I had for the limited time I had to live.”

20 Years Since an EGFR Discovery, a Woman With Stage IV Lung Cancer Is Thriving

Health

Medically reviewed by Marla Anderson, MDMedically reviewed by Marla Anderson, MDNon-small cell lung cancer (NSCLC) is a type of cancer that begins in the tissues of the lungs. About 80-85% of all lung cancer cases in the United States are classified as NSCLC. NSCLC occurs when the cells that line the surface of the lung airways change and mutate. When these abnormal cells rapidly divide and multiply, they lead to cancer. The most common cause of NSCLC is smoking, with about 90% of lung cancer cases being related to tobacco smoke exposure. It is possible to be diagnosed with NSCLC if you...

What Causes Non-Small Cell Lung Cancer (NSCLC)?

New research indicates that more efficient treatment methods are available for patients undergoing CAR-T cell therapy, suggesting that current FDA guidelines mandating that patients remain close to treatment centers for four weeks after receiving the therapy results in unnecessary challenges and additional medical costs. According to the findings, extending close...

CAR-T Cell Therapy Cancer Risks May Drop Off After Two Weeks of Therapy: Study

Cancer cells can hijack cell cycles to exponentially increase their numbers, a process called proliferation. Cancer drugs can stop the growth of cancer cells by jumpstarting a complex chain of genetic and cellular events. But often, this story is more complex, involving treatments that don’t work as well as had been hoped.

How Do Cancer Cells Divide Despite Treatment?

Researchers have demonstrated that adding metastasis-directed radiation therapy to standard-of-care chemotherapy may improve progression-free survival in patients with oligometastatic pancreatic cancer, according to a recent study published by Ludmir et al in the Journal of Clinical Oncology and previously presented at the 2024 ASCO Gastrointestinal Cancers Symposium (Abstract 603). Background.

Metastasis-Directed Radiation Therapy Plus Chemotherapy in Oligometastatic Pancreatic Cancer

The Oklahoma City Sentinel

(StatePoint) A bladder cancer diagnosis can be scary, but according to those who’ve been through it, advocating for yourself and taking charge of your journey can help you make informed decisions when it comes to your treatment to get the best care possible.
                “For me, a second opinion turned an originally doom-and-gloom picture into a more hopeful, optimistic and clear path forward,” said Mary Beth M., a bladder cancer survivor. “It’s so important to seek a second or even a third opinion if you feel...

What to Know After a Bladder Cancer Diagnosis

Breyanzi demonstrated an overall high response rate in adults with relapsed or refractory follicular lymphoma in a Phase II study. The European Medicines Agency (EMA) has validated a Type II variation application that expands the indication for Breyanzi, a Bristol Myers Squibb product, to include treatment of adults with relapsed or refractory follicular lymphoma (FL) who have received two or more prior lines of systemic therapy (1). The validation, which confirms the completion of the therapy’s submission to EMA and allows scientific review to begin, was announced by Bristol Myers Squibb in a press release on Aug. 19, 2024.

Bristol Myers Squibb Follicular Lymphoma Therapy Gets Expanded EMA Indication

Imagine tiny fists punching their way through your body. For some cancer patients, this may be the reality. Melanoma cells can mechanically tunnel their way through tissue using fleshy membrane protrusions without the need for chemicals that chew up the environment, researchers report June 12 in Developmental Cell. Cells have...

Some melanoma cancer cells may punch their way through the body

Adrenal cancer is a rare but serious condition that affects the adrenal glands, which sit atop your kidneys. These glands produce hormones that regulate metabolism, immune system, blood pressure, and other essential functions. Adrenal cancer can disrupt these processes, leading to a variety of symptoms and complications. Understanding this disease is crucial for early detection and treatment. In this post, we'll share 25 facts about adrenal cancer to help you grasp its impact, symptoms, and treatment options. From the basics of what adrenal glands do to the latest advancements in medical research, you'll gain a comprehensive overview of this challenging condition.

25 Facts About Adrenal Cancer

Atlanta, GA

ATLANTA — Researchers using Georgia State University’s Center for High Angular Resolution Astronomy (CHARA) Array have identified new details about the size and appearance of the North Star, also known as Polaris. The new research is published in The Astrophysical Journal. Earth’s North Pole points to a direction...

New view of North Star reveals spotted surface

Colorado State

Contributors represent independent, third-party users who have joined our contributor program and self-verified their accounts. They have also demonstrated their experience writing hard news for other outlets. Contributors are expected, like all users, to adhere to our Community Standards.

contributor

David Heitz

A bill quietly introduced this spring in the Colorado legislature to decriminalize the possession of drug paraphernalia obtained by harm reductionists has become law. As low-key as the legislation was introduced, the bill was signed into law without fanfare June 6. It garnered little to no media attention.

Colorado legalizes needles, pipes for meth and crack if obtained by harm reduction group

Ovarian cancer is one of the leading causes of cancer death among women, with nearly 20,000 new diagnoses each year and around 12,740 deaths from the disease estimated in 2024, according to the American Cancer Society. Researchers at the University of Colorado Cancer Center have recently published two research papers...

New Research in the Fight Against Ovarian Cancer

A rare form of endometrial cancer - uterine serous carcinoma – is more aggressive in Black women compared to white women, according to a new study published in the medical journal Proceedings of the National Academy of Sciences.

As Howard Stern’s Sidekick Robin Quivers, 71, Embraces ‘Bald Hairdo’ Amid Endometrial Cancer, New Study Finds a Rare Form of the Cancer Is More Aggressive In Black Women

In new research published in the scientific journal Discover Food, Dr. Asaf Tzachor, Founder and Academic Director of the Aviram Sustainability and Climate Program at Reichman University, along with a team of researchers from Iceland, Denmark and Austria, report the use of state-of-the-art biotechnology to cultivate photosynthetically-controlled Spirulina, and produce carbon–neutral and nutritious biomass containing unopposed, biologically active vitamin B12, in levels comparable to beef meat. This is the first time biologically active vitamin B12 has been reported in Spirulina.

Breakthrough study unveils sustainable solution to vitamin B12 deficiency

New York Post

One of the biggest mysteries of cancer is why it predominantly and almost exclusively targets people in middle age or older. 

During the first five decades of life, you’re twice as likely to die in a car crash than from cancer. But that changes abruptly at the half-century mark. “90% of cancers come up after the age of 50,” says James DeGregori, Ph.D., the deputy director of the University of Colorado Cancer Center.



Why do our bodies suddenly stop being as effective in keeping cancer at bay after 50? There are theories — there’s more accumulated cell damage, our immune systems lose...

Why does cancer risk skyrocket as we age? How ‘inflammaging’ is the new tool to end the disease

Approval marks the first multitargeted regimen to surpass Tagrisso in efficacy in the first-line treatment of advanced non-small cell lung cancer, according to Johnson & Johnson. The FDA has approved Johnson & Johnson’s (J&J) combination of Rybrevant (amivantamab-vmjw) and Lazcluze (lazertinib) as a first-line, chemotherapy-free treatment for advanced non-small cell...

FDA Approves Johnson & Johnson’s Rybrevant and Lazcluze for Advanced Non-Small Cell Lung Cancer

MadameNoire

The recent study emphasizes the urgent need for advanced technologies to treat and potentially cure breast cancer.

Double Mastectomy Treatment May Not Increase Cancer Survival Rate, New Study Reveals

NewsBreak

Targeting cancer with precision: neoantigen vaccines show promise

In an elegant fusion of science and medicine, neoantigen cancer vaccines are emerging as a formidable strategy in the battle against cancer. These vaccines, a testament...

Targeting cancer with precision: neoantigen vaccines show promise

Comments / 0